Clinical Cardiology Alert – June 1, 2016
June 1, 2016
View Issues
-
New Analysis of COGENT Data Supports Proton Pump Inhibitor Benefit
It shows comparable risks of gastrointestinal and cardiovascular events between low- and high-dose aspirin.
-
Rivaroxaban in the Real World
A large Phase IV registry study shows that rivaroxaban is associated with a very low incidence of major bleeding, death, or stroke. Also, adherence to therapy was much higher than observed in other studies with vitamin K antagonists.
-
Atrial Fibrillation Ablation in Heart Failure Patients May Be Particularly Beneficial
Atrial fibrillation ablation leads to better outcomes in heart failure patients compared to amiodarone.
-
Can MRI Diagnose Myocarditis?
New quantitative MRI technique performs better than the older Lake Louise criteria for diagnosing myocarditis as compared to the standard of endomyocardial biopsy.
-
Noninvasive Diagnosis of Transthyretin Amyloid Cardiomyopathy
A testing strategy combining bone scintigraphy and laboratory testing allows accurate diagnosis of transthyretin amyloid cardiomyopathy without the need for a biopsy.